324 related articles for article (PubMed ID: 32593402)
1. Advances in insulin-like growth factor biology and -directed cancer therapeutics.
Fettig LM; Yee D
Adv Cancer Res; 2020; 147():229-257. PubMed ID: 32593402
[TBL] [Abstract][Full Text] [Related]
2. Targeting the insulin growth factor receptor 1.
Arnaldez FI; Helman LJ
Hematol Oncol Clin North Am; 2012 Jun; 26(3):527-42, vii-viii. PubMed ID: 22520978
[TBL] [Abstract][Full Text] [Related]
3. Minireview: IGF, Insulin, and Cancer.
Gallagher EJ; LeRoith D
Endocrinology; 2011 Jul; 152(7):2546-51. PubMed ID: 21540285
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy of the insulin-like growth factor-1 receptor in cancer.
Paz K; Hadari YR
Comb Chem High Throughput Screen; 2008 Jan; 11(1):62-9. PubMed ID: 18220543
[TBL] [Abstract][Full Text] [Related]
5. Targeting the type I insulin-like growth factor system for breast cancer therapy.
Sachdev D
Curr Drug Targets; 2010 Sep; 11(9):1121-32. PubMed ID: 20545608
[TBL] [Abstract][Full Text] [Related]
6. The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer.
Heidegger I; Massoner P; Sampson N; Klocker H
Cancer Lett; 2015 Oct; 367(2):113-21. PubMed ID: 26231734
[TBL] [Abstract][Full Text] [Related]
7. Targeting the insulin-like growth factor network in cancer therapy.
Heidegger I; Pircher A; Klocker H; Massoner P
Cancer Biol Ther; 2011 Apr; 11(8):701-7. PubMed ID: 21311212
[TBL] [Abstract][Full Text] [Related]
8. Targeting the IGF1 axis in cancer proliferation.
Bruchim I; Attias Z; Werner H
Expert Opin Ther Targets; 2009 Oct; 13(10):1179-92. PubMed ID: 19663648
[TBL] [Abstract][Full Text] [Related]
9. Targeting insulin-like growth factor signaling: rational combination strategies.
Olmos D; Basu B; de Bono JS
Mol Cancer Ther; 2010 Sep; 9(9):2447-9. PubMed ID: 20807783
[No Abstract] [Full Text] [Related]
10. The possible role of insulin-like growth factor-1 in osteosarcoma.
Li YS; Liu Q; He HB; Luo W
Curr Probl Cancer; 2019 Jun; 43(3):228-235. PubMed ID: 30217668
[TBL] [Abstract][Full Text] [Related]
11. Cell-associated insulin-like growth factor-binding proteins inhibit insulin-like growth factor-I-induced endometrial cancer cell proliferation.
Bermont L; Fauconnet S; Lamielle F; Adessi GL
Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1173-82. PubMed ID: 11075947
[TBL] [Abstract][Full Text] [Related]
12. Combination of two insulin-like growth factor-I receptor inhibitory antibodies targeting distinct epitopes leads to an enhanced antitumor response.
Dong J; Demarest SJ; Sereno A; Tamraz S; Langley E; Doern A; Snipas T; Perron K; Joseph I; Glaser SM; Ho SN; Reff ME; Hariharan K
Mol Cancer Ther; 2010 Sep; 9(9):2593-604. PubMed ID: 20716637
[TBL] [Abstract][Full Text] [Related]
13. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
14. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic and antineoplastic activity of BI 836845, a fully human IGF ligand-neutralizing antibody, and mechanistic rationale for combination with rapamycin.
Friedbichler K; Hofmann MH; Kroez M; Ostermann E; Lamche HR; Koessl C; Borges E; Pollak MN; Adolf G; Adam PJ
Mol Cancer Ther; 2014 Feb; 13(2):399-409. PubMed ID: 24296829
[TBL] [Abstract][Full Text] [Related]
16. Aiming for the Insulin-like Growth Factor-1 system in breast cancer therapeutics.
Christopoulos PF; Corthay A; Koutsilieris M
Cancer Treat Rev; 2018 Feb; 63():79-95. PubMed ID: 29253837
[TBL] [Abstract][Full Text] [Related]
17. Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthma.
Lee H; Kim SR; Oh Y; Cho SH; Schleimer RP; Lee YC
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):667-77. PubMed ID: 24219511
[TBL] [Abstract][Full Text] [Related]
18. Bad to the Bone: The Role of the Insulin-Like Growth Factor Axis in Osseous Metastasis.
Rieunier G; Wu X; Macaulay VM; Lee AV; Weyer-Czernilofsky U; Bogenrieder T
Clin Cancer Res; 2019 Jun; 25(12):3479-3485. PubMed ID: 30745299
[TBL] [Abstract][Full Text] [Related]
19. Advances in targeting insulin-like growth factor signaling pathway in cancer treatment.
You L; Liu C; Tang H; Liao Y; Fu S
Curr Pharm Des; 2014; 20(17):2899-911. PubMed ID: 23944362
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor signaling as a therapeutic target in pancreatic cancer.
Rieder S; Michalski CW; Friess H; Kleeff J
Anticancer Agents Med Chem; 2011 Jun; 11(5):427-33. PubMed ID: 21492074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
